Valeo Financial Advisors, LLC Edwards Lifesciences Corp Transaction History

Valeo Financial Advisors, LLC

$3.81 Billion
Q3 2024

A detailed history of Valeo Financial Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 4,486 shares of EW stock, worth $303,971. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,486

Previous 5,133 12.6%

Holding current value

$303,971

Previous $474,000 37.55%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$59.7 - $93.78 $38,625 - $60,675	-647 Reduced 12.6%	4,486 $296,000
Q2 2024 Jul 10, 2024	BUY	$84.3 - $94.31 $29,842 - $33,385	354 Added 7.41%	5,133 $474,000
Q1 2024 Apr 25, 2024	BUY	$72.54 - $95.56 $1,160 - $1,528	16 Added 0.34%	4,779 $456,000
Q1 2024 Apr 19, 2024	SELL	$72.54 - $95.56 $25,243 - $33,254	-348 Reduced 6.81%	4,763 $455,000
Q4 2023 Jan 29, 2024	BUY	$61.71 - $77.76 $122,062 - $153,809	1,978 Added 63.13%	5,111 $389,000
Q3 2023 Oct 19, 2023	SELL	$69.28 - $93.38 $125,951 - $169,764	-1,818 Reduced 36.72%	3,133 $217,000
Q2 2023 Jul 14, 2023	BUY	$81.41 - $94.33 $45,752 - $53,013	562 Added 12.8%	4,951 $467,000
Q1 2023 Apr 17, 2023	BUY	$74.26 - $84.51 $116,216 - $132,258	1,565 Added 55.42%	4,389 $363,000
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $192,879 - $246,930	2,824 New	2,824 $210,000
Q2 2021 Jul 22, 2021	SELL	$83.84 - $104.76 $81,240 - $101,512	-969 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $3,226 - $4,105	-45 Reduced 4.44%	969 $88,000
Q3 2020 Oct 28, 2020	SELL	$67.19 - $87.44 $37,492 - $48,791	-558 Reduced 35.5%	1,014 $81,000
Q2 2020 Jul 20, 2020	BUY	$57.54 - $76.95 $60,071 - $80,335	1,044 Added 197.73%	1,572 $109,000
Q1 2020 Apr 13, 2020	BUY	$52.41 - $81.0 $2,987 - $4,617	57 Added 12.1%	528 $113,000
Q4 2019 Jan 24, 2020	BUY	$71.7 - $82.09 $5,019 - $5,746	70 Added 17.46%	471 $110,000
Q3 2019 Oct 15, 2019	SELL	$61.55 - $75.43 $307 - $377	-5 Reduced 1.23%	401 $88,000
Q2 2019 Jul 10, 2019	SELL	$55.74 - $64.41 $3,511 - $4,057	-63 Reduced 13.43%	406 $75,000
Q1 2019 Apr 12, 2019	BUY	$47.89 - $64.05 $766 - $1,024	16 Added 3.53%	469 $90,000
Q4 2018 Jan 30, 2019	BUY	$46.41 - $56.94 $371 - $455	8 Added 1.8%	453 $69,000
Q3 2018 Nov 01, 2018	BUY	$45.7 - $58.03 $822 - $1,044	18 Added 4.22%	445 $65,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $1,740 - $2,103	-41 Reduced 8.76%	427 $59,000
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $7,467 - $8,705	221 Added 89.47%	468 $53,000
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $8,963 - $9,591	247	247 $27,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Account

Valeo Financial Advisors, LLC Edwards Lifesciences Corp Transaction History